BackHTG Molecular Diagnostics Overview

HTG Molecular Diagnostics Current Cash

Track HTG Molecular Diagnostics's current cash ($3M) with charts, peers, and YoY trends.

Get informed when a big investor buys or sells

+ Follow
Current Cash
$3.00M
↓ 79.50% YoYΔ $-11.62M vs prior year quarter

Peer average

Loading

HTG Molecular Diagnostics Current Cash History

Loading

HTG Molecular Diagnostics vs. peers: Current Cash Comparison

Loading

HTG Molecular Diagnostics Cash Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Balance Sheet Breakdown

Current CashShort Term InvestmentsReceivablesInventoryOther Current AssetsCurrent AssetsLong Term InvestmentsProperty Plant EquipmentGoodwillIntangible AssetsOther AssetsTotal AssetsNet Tangible AssetsAccounts PayableOther Current LiabilitiesTotal Current LiabilitiesLong Term DebtOther LiabilitiesMinority InterestTotal Liabilities

HTG Molecular Diagnostics (HTGM) FAQ

HTG Molecular Diagnostics (HTGM) currently reports a current cash of $3M as of March 2023. That compares with $15M in the prior-year period — down 79.5% year over year. Use the charts on this page to explore HTG Molecular Diagnostics's current cash history and peer comparisons.

HTG Molecular Diagnostics's current cash decreased from $15M to $3M — a 79.5% year-over-year decrease (period ending March 2023). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

HTG Molecular Diagnostics reported $3M in current cash as of March 2023. That compares with $15M in the prior-year period — down 79.5% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current current cash of $3M, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for HTG Molecular Diagnostics, and consider following HTGM for alerts when major investors trade the stock.

HTG Molecular Diagnostics is classified in the Healthcare sector. On current cash, it currently shows $3M. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing HTGM with unrelated industries.